Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
113.6 CHF | +0.71% | -3.57% | +10.29% |
Nov. 30 | Medacta to Expand Swiss Facilities to Boost Production Capacity | MT |
Oct. 30 | Medacta Group to Launch Optimized Knee Implant | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Calendar
2024-03-13
- Q4 2023 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
120.12EUR
Average target price
137.58EUR
Spread / Average Target
+14.54%
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.29% | 2 586 M $ | |
-5.23% | 181 B $ | |
+2.35% | 106 B $ | |
-8.16% | 67 420 M $ | |
+4.99% | 45 936 M $ | |
+20.82% | 39 844 M $ | |
+44.97% | 25 245 M $ | |
-8.01% | 24 511 M $ | |
+25.60% | 24 471 M $ | |
+29.93% | 23 982 M $ |
- Stock
- Equities
- Stock Medacta Group SA - Swiss Exchange
- News Medacta Group SA
- Medacta Group Completes First MyPAO Surgery in Europe